Published in J Hand Surg Br on October 01, 2005
Treatment of ulnar nerve compression at the elbow. J Hand Surg Am (2008) 1.61
Cubital tunnel syndrome. Postgrad Med J (2007) 1.08
Trend of recovery after simple decompression for treatment of ulnar neuropathy at the elbow. Plast Reconstr Surg (2013) 0.96
Cubital tunnel syndrome - Review of current literature on causes, diagnosis and treatment. J Hand Microsurg (2010) 0.87
Minimal-incision in situ ulnar nerve decompression at the elbow. Hand Clin (2013) 0.87
Simple decompression of the ulnar nerve for cubital tunnel syndrome. J Korean Neurosurg Soc (2007) 0.81
Modified simple decompression of ulnar nerve in treatment of cubital tunnel syndrome. World J Plast Surg (2012) 0.79
Surgical Treatment of Cubital Tunnel Syndrome: Trends and the Influence of Patient and Surgeon Characteristics. J Hand Surg Am (2015) 0.78
Anterior Subcutaneous versus Submuscular Transposition of the Ulnar Nerve for Cubital Tunnel Syndrome: A Systematic Review and Meta-Analysis. PLoS One (2015) 0.77
Setting expectations following endoscopic cubital tunnel release. Hand (N Y) (2014) 0.76
Subcutaneous Versus Submuscular Anterior Transposition of the Ulnar Nerve for Cubital Tunnel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies. Medicine (Baltimore) (2015) 0.75
The effect of operative technique on ulnar nerve strain following surgery for cubital tunnel syndrome. Hand (N Y) (2015) 0.75
Our early experience in surgical and clinical outcome on endoscopic cubital tunnel release: a preliminary result. ISRN Orthop (2011) 0.75
Cubital compressive neuropathy in the elbow: in situ neurolysis versus anterior transposition - comparative study. Rev Bras Ortop (2014) 0.75
Postoperative improvement in DASH score, clinical findings, and nerve conduction velocity in patients with cubital tunnel syndrome. Sci Rep (2016) 0.75
SUBCUTANEOUS ANTERIOR TRANSPOSITION FOR TREATMENT OF CUBITAL TUNNEL SYNDROME: IS THIS METHOD SAFE AND EFFECTIVE? Rev Bras Ortop (2015) 0.75
Simple decompression did not differ from simple decompression plus anterior transposition of the nerve for cubital tunnel syndrome. J Bone Joint Surg Am (2006) 0.75
Surgical options for ulnar nerve entrapment: an example of individualized decision analysis. Hand (N Y) (2009) 0.75
The Blocking Flap for Ulnar Nerve Instability After In Situ Release: Technique and a Grading System of Ulnar Nerve Instability to Guide Treatment. Tech Hand Up Extrem Surg (2017) 0.75
Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res (1999) 12.83
Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding. Nature (2000) 2.57
Regulation of MHC class II genes: lessons from a disease. Annu Rev Immunol (1996) 2.42
A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev (1995) 2.33
CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev (2000) 2.19
The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol (2008) 2.08
The transcription factor RFX3 directs nodal cilium development and left-right asymmetry specification. Mol Cell Biol (2004) 1.87
A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat Genet (1998) 1.84
Support and faculty mentoring programmes for medical students in Germany, Switzerland and Austria. Med Educ (2000) 1.74
RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom. Nucleic Acids Res (1996) 1.71
Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions. Stroke (2010) 1.69
Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency. N Engl J Med (1997) 1.60
Revascularization in acute ischaemic stroke using the penumbra system: the first single center experience. Eur J Neurol (2009) 1.59
[Cubital tunnel syndrome--simple nerve decompression or decompression with subcutaneous anterior transposition?]. Fortschr Neurol Psychiatr (2007) 1.55
Disc replacement using Pro-Disc C versus fusion: a prospective randomised and controlled radiographic and clinical study. Eur Spine J (2006) 1.51
Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle. Oncogene (1998) 1.51
Comparison of stent free cell area and cerebral lesions after unprotected carotid artery stent placement. Eur J Vasc Endovasc Surg (2011) 1.51
[Diagnosis and therapy of carpal tunnel syndrome--guideline of the German Societies of Handsurgery, Neurosurgery, Neurology, Orthopaedics, Clinical Neurophysiology and Functional Imaging, Plastic, Reconstructive and Aesthetic Surgery, and Surgery for Traumatology]. Handchir Mikrochir Plast Chir (2007) 1.51
Mobile stroke unit for diagnosis-based triage of persons with suspected stroke. Neurology (2012) 1.49
Induction of HLA class II genes by IFN-gamma is transcriptional and requires a trans-acting protein. J Immunol (1989) 1.46
RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer. Mol Cell Biol (1993) 1.46
Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J Exp Med (1994) 1.46
RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J (1997) 1.45
A practice audit of oral contraceptive users. Br Med J (Clin Res Ed) (1983) 1.44
Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression. J Exp Med (2001) 1.40
Cloning and functional characterization of mammalian homologues of the COPII component Sec23. Mol Biol Cell (1996) 1.39
CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation. Mol Cell Biol (2000) 1.39
Cubital tunnel syndrome - a review and management guidelines. Cent Eur Neurosurg (2011) 1.39
A consensus motif in the RFX DNA binding domain and binding domain mutants with altered specificity. Mol Cell Biol (1996) 1.37
Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene. J Exp Med (2001) 1.32
Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX. Mol Cell Biol (1994) 1.30
Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression. Immunol Rev (2000) 1.23
Two DNA-binding proteins discriminate between the promoters of different members of the major histocompatibility complex class II multigene family. Mol Cell Biol (1990) 1.22
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy. Am J Hum Genet (2006) 1.21
A deficiency in RFX3 causes hydrocephalus associated with abnormal differentiation of ependymal cells. Eur J Neurosci (2006) 1.21
Endovascular treatment of brain arteriovenous malformations using a liquid embolic agent: results of a prospective, multicentre study (BRAVO). Eur Radiol (2013) 1.19
Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease. Tissue Antigens (2006) 1.18
Trismus in postoperative, posttraumatic and other brain stem lesions caused by paradoxical activity of masticatory muscles. Acta Neurochir (Wien) (1985) 1.17
MHC class II-deficient combined immunodeficiency: a disease of gene regulation. Immunol Rev (1994) 1.14
Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome. J Immunol (1995) 1.13
Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice. Immunity (1998) 1.12
Therapy of invasive mucoceles of the frontal sinus. Rhinology (2001) 1.10
Simultaneous assessment of cerebral hemodynamics and contrast agent uptake in lesions with disrupted blood-brain-barrier. Magn Reson Imaging (1999) 1.09
Dimeric RFX proteins contribute to the activity and lineage specificity of the interleukin-5 receptor alpha promoter through activation and repression domains. Mol Cell Biol (1999) 1.09
A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y. Mol Cell Biol (2000) 1.06
Segmental kinematics and adjacent level degeneration following disc replacement versus fusion: RCT with three years of follow-up. J Long Term Eff Med Implants (2007) 1.06
The DNA-binding defect observed in major histocompatibility complex class II regulatory mutants concerns only one member of a family of complexes binding to the X boxes of class II promoters. Mol Cell Biol (1992) 1.05
Organization and sequence analysis of a cluster of repetitive DNA elements from Xenopus laevis. J Mol Biol (1981) 1.04
Traumatic brain injury: cause or risk of Alzheimer's disease? A review of experimental studies. J Neural Transm (Vienna) (2005) 1.03
PHF3-specific antibody responses in over 60% of patients with glioblastoma multiforme. Oncogene (2001) 1.02
Malignant rhabdoid tumor: primary intracranial manifestation in an adult. Acta Neuropathol (1992) 1.01
Time course of the apparent diffusion coefficient after cerebral infarction. Eur Radiol (2002) 1.01
Screw fixation to the posterior cortical shell does not influence peak torque and pullout in anterior cervical plating. Eur Spine J (2002) 1.00
Assessment of adjacent-segment mobility after cervical disc replacement versus fusion: RCT with 1 year's results. Eur Spine J (2011) 0.99
Differential release of interleukines 6, 8, and 10 in cerebrospinal fluid and plasma after traumatic brain injury. Shock (2001) 0.99
Glioma-expressed antigen 2 (GLEA2): a novel protein that can elicit immune responses in glioblastoma patients and some controls. Clin Exp Immunol (2001) 0.98
Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Acta Neurochir (Wien) (1995) 0.98
Dissection of functional NF-Y-RFX cooperative interactions on the MHC class II Ea promoter. J Mol Biol (2000) 0.97
Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis. Eur J Immunol (2000) 0.97
Decompressive craniectomy in a rat model of "malignant" cerebral hemispheric stroke: experimental support for an aggressive therapeutic approach. J Neurosurg (1996) 0.97
Novel tankyrase-related gene detected with meningioma-specific sera. Clin Cancer Res (2001) 0.96
Decompressive craniectomy for cerebral infarction. An experimental study in rats. Stroke (1995) 0.96
Cognitive changes after carotid artery stenting. Neuroradiology (2006) 0.96
Regulatory factor-X binding to mutant HLA-DRA promoter sequences. Nucleic Acids Res (1991) 0.96
Multifocal Signal Loss at Bridging Veins on Susceptibility-Weighted Imaging in Abusive Head Trauma. Clin Neuroradiol (2014) 0.95
Molecular genetics of the Bare lymphocyte syndrome. Rev Immunogenet (2000) 0.95
Primary immunodeficiency mutation databases. Adv Genet (2001) 0.95
MHC class II deficiency: a disease of gene regulation. Medicine (Baltimore) (2001) 0.94
Inherited immunodeficiency with a defect in a major histocompatibility complex class II promoter-binding protein differs in the chromatin structure of the HLA-DRA gene. Mol Cell Biol (1989) 0.94
The different level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in promoter sequence. Hum Immunol (1993) 0.94
Epidemiology and prevention of fatal head injuries in Germany--trends and the impact of the reunification. Acta Neurochir (Wien) (2005) 0.93
Mechanical behaviour of standardized, endoskeleton-including hip spacers implanted into composite femurs. Int J Med Sci (2009) 0.92
Hyperperfusion syndrome after carotid stent angioplasty. Neuroradiology (2008) 0.92
Evaluation of a new monocortical screw for anterior cervical fusion and plating by a combined biomechanical and clinical study. Eur Spine J (1999) 0.92
Clathrin-coated pit-mediated receptor internalization. Role of internalization signals and receptor mobility. J Biol Chem (1993) 0.92
Peri-interventional Subarachnoid Hemorrhage During Mechanical Thrombectomy with stent retrievers in Acute Stroke: A Retrospective Case-Control Study. Clin Neuroradiol (2014) 0.90
Delayed vascular injury after single high-dose irradiation in the rat brain: histologic immunohistochemical, and angiographic studies. Radiology (1999) 0.90
Spiral CT vs incremental CT: is spiral CT superior in imaging of the brain? Eur Radiol (1998) 0.90
Thalamic volumes in patients with bipolar disorder. Eur Arch Psychiatry Clin Neurosci (2010) 0.89
[Vascular anomalies of the cerebellopontine angle]. Radiologe (2006) 0.89
Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP. Mol Cell Biol (2001) 0.89
Filling a cervical spine cage with local autograft: change of bone density and assessment of bony fusion. Zentralbl Neurochir (2006) 0.88
Development of a reinforced PMMA-based hip spacer adapted to patients' needs. Med Eng Phys (2009) 0.88
Patterns of relapse and late toxicity after resection and whole-brain radiotherapy for solitary brain metastases. Strahlenther Onkol (1998) 0.88
CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes. Int Immunol (1999) 0.88
Cerebral phaeohyphomycosis caused by an Exophiala species. Mycoses (1992) 0.88
Changes in linear dynamics of cerebrovascular system after severe traumatic brain injury. Stroke (2003) 0.87
Gender-specific differences in school sports injuries. Sportverletz Sportschaden (2004) 0.87
Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: a retrospective study of 198 cases. J Neurosurg (2001) 0.87
Structural analysis of a cDNA clone from Xenopus laevis containing a repetitive sequence element. Dev Biol (1982) 0.86
Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas. Clin Cancer Res (1999) 0.86
Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B. Immunogenetics (2000) 0.86
Faculty mentoring programme--ways of reducing anonymity. Med Educ (1998) 0.86